The past decades have witnessed hyperthermia therapy (HTT) as an emerging strategy
against malignant tumors. Nanomaterial‐based photothermal therapy (PTT) and magnetic …

Immunotherapy is often perceived as a relatively recent advance. In reality, however, one
should be looking for the beginnings of cancer immunotherapy under different names as far …

The therapeutic efficacy of whole tumor cell vaccines (TCVs) is modest, which has delayed
their translation into personalized immunotherapies in the clinic. Here, we develop a TCV …

Nanovaccine-based immunotherapy has been considered as a major pillar to stimulate the
host immune system to recognize and eradicate tumor cells as well as establish a long-term …

Immunotherapy has emerged as a breakthrough strategy in cancer treatment. mRNA
vaccines are an attractive and powerful immunotherapeutic platform against cancer because …

Nanoparticles having magnetic and fluorescent properties could be considered as a gift to
materials scientists due to their unique magneto-optical qualities. Multiple component …

Lung cancer has a poor prognosis; over half of people diagnosed with lung cancer die
within one year of diagnosis and the 5-year survival is less than 18%. Non-small cell lung …

Anticancer vaccines train the body's own immune system to recognize and eliminate
malignant cells based on differential antigen expression. While conceptually attractive …

Tumor vaccination is a promising approach for tumor immunotherapy because it presents
high specificity and few side effects. However, tumor vaccines that contain only a single …

Cancer immunotherapy uses the immune system and its components to mount an anti-tumor
response. During the last decade, it has evolved from a promising therapy option to a robust …